Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients

Annals of Oncology

DOI: 10.1093/annonc/mdq726 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 6 stored of 161

Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale
2025 Quality of Life Research article Medicine Cancer survivorship and care Open access

3

citations
Health-Related Quality of Life in Neuro-Oncology
2025 Elsevier eBooks book-chapter Medicine Cancer survivorship and care

0

citations
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)
2023 European Journal of Cancer article Medicine Glioma Diagnosis and Treatment Open access

13

citations
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types
2023 European Journal of Cancer article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access

190

citations
Health-Related Quality of Life in Intracranial Meningioma: Current Evidence and Future Directions
2023 Advances in experimental medicine and biology book-chapter Medicine Meningioma and schwannoma management

5

citations
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
2021 Neuro-Oncology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access

46

citations

6 results

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients

Authors 0

Cited by 6 stored of 161

References 0